» Articles » PMID: 20160199

Modulation of Mitochondrial Proteome and Improved Mitochondrial Function by Biventricular Pacing of Dyssynchronous Failing Hearts

Abstract

Background: Cardiac resynchronization therapy (CRT) improves chamber mechanoenergetics and morbidity and mortality of patients manifesting heart failure with ventricular dyssynchrony; however, little is known about the molecular changes underlying CRT benefits. We hypothesized that mitochondria may play an important role because of their involvement in energy production.

Methods And Results: Mitochondria isolated from the left ventricle in a canine model of dyssynchronous or resynchronized (CRT) heart failure were analyzed by a classical, gel-based, proteomic approach. Two-dimensional gel electrophoresis revealed that 31 mitochondrial proteins where changed when controlling the false discovery rate at 30%. Key enzymes in anaplerotic pathways, such as pyruvate carboxylation and branched-chain amino acid oxidation, were increased. These concerted changes, along with others, suggested that CRT may increase the pool of Krebs cycle intermediates and fuel oxidative phosphorylation. Nearly 50% of observed changes pertained to subunits of the respiratory chain. ATP synthase-beta subunit of complex V was less degraded, and its phosphorylation modulated by CRT was associated with increased formation (2-fold, P=0.004) and specific activity (+20%, P=0.05) of the mature complex. The importance of these modifications was supported by coordinated changes in mitochondrial chaperones and proteases. CRT increased the mitochondrial respiratory control index with tightened coupling when isolated mitochondria were reexposed to substrates for both complex I (glutamate and malate) and complex II (succinate), an effect likely related to ATP synthase subunit modifications and complex quantity and activity.

Conclusions: CRT potently affects both the mitochondrial proteome and the performance associated with improved cardiac function.

Citing Articles

Multipoint Left Ventricular Pacing as Alternative Approach in Cases of Biventricular Pacing Failure.

Antoniou C, Chrysohoou C, Manolakou P, Tsiachris D, Kordalis A, Tsioufis K J Clin Med. 2025; 14(4).

PMID: 40004595 PMC: 11856938. DOI: 10.3390/jcm14041065.


Concepts of Cardiac Dyssynchrony and Dynamic Approach.

Catrina B, Batar F, Manitiu I, Prodan L, Tanasescu C, Filip T Diagnostics (Basel). 2024; 14(9).

PMID: 38732350 PMC: 11083078. DOI: 10.3390/diagnostics14090937.


Proteomics of the heart.

Karpov O, Stotland A, Raedschelders K, Chazarin B, Ai L, Murray C Physiol Rev. 2024; 104(3):931-982.

PMID: 38300522 PMC: 11381016. DOI: 10.1152/physrev.00026.2023.


Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential.

Martin T, Juarros M, Leinwand L Nat Rev Cardiol. 2023; 20(5):347-363.

PMID: 36596855 PMC: 10121965. DOI: 10.1038/s41569-022-00806-6.


Cardio-Onco-Metabolism - Metabolic vulnerabilities in cancer and the heart.

Karlstaedt A, Taegtmeyer H J Mol Cell Cardiol. 2022; 171:71-80.

PMID: 35777454 PMC: 10193535. DOI: 10.1016/j.yjmcc.2022.06.008.


References
1.
Glatz J, Bonen A, Ouwens D, Luiken J . Regulation of sarcolemmal transport of substrates in the healthy and diseased heart. Cardiovasc Drugs Ther. 2006; 20(6):471-6. DOI: 10.1007/s10557-006-0582-8. View

2.
Spragg D, Kass D . Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis. 2006; 49(1):26-41. DOI: 10.1016/j.pcad.2006.05.001. View

3.
Spragg D, Akar F, Helm R, Tunin R, Tomaselli G, Kass D . Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovasc Res. 2005; 67(1):77-86. DOI: 10.1016/j.cardiores.2005.03.008. View

4.
Arrell D, Elliott S, Kane L, Guo Y, Ko Y, Pedersen P . Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res. 2006; 99(7):706-14. DOI: 10.1161/01.RES.0000243995.74395.f8. View

5.
Santoni V, Molloy M, Rabilloud T . Membrane proteins and proteomics: un amour impossible?. Electrophoresis. 2000; 21(6):1054-70. DOI: 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.0.CO;2-8. View